Interim analysis of the phase II study: Noninferiority study of doxorubicin with upfront dexrazoxane plus olaratumab for advanced or metastatic soft-tissue Sarcoma A C
- Brian A. van Tine
- , Angela C. Hirbe
- , Peter Oppelt
- , Ashley E. Frith
- , Richa Rathore
- , Joshua D. Mitchell
- , Fei Wan
- , Shellie Berry
- , Michele Landeau
- , George A. Heberton
- , John Gorcsan
- , Peter R. Huntjens
- , Yoku Soyama
- , Justin M. Vader
- , Jose A. Alvarez-Cardona
- , Kathleen W. Zhang
- , Daniel J. Lenihan
- , Ronald J. Krone
Research output: Contribution to journal › Article › peer-review
18
Link opens in a new tab
Scopus
citations